JAMA Neurology, 75(5), 608-619. American Medical Association Villeneuve, S, Vogel, J W, Gonneaud, J, Pichet Binette, A, Rosa-Neto, P, Gauthier, S, Bateman, R J, Fagan, A M, Morris, J C, Benzinger, T L S, Johnson, S C, Breitner, J C S, Poirier, J, Barkun, A, Evans, A, Salaciak, A, Tam, A, Labonté, A, Faubert, A-M, Mathieu, A, Courcot, B, Hyman, B T, Madjar, C C, Carrier, C E, Dansereau, C, Kazazian, C, Tardif, C, Lepage, C, Cuello, C, Debacker, C, Jack, C R, Picard, C, Maillet, D, Fontaine, D, Knopman, D S, Michaud, D, Couture, D, Dea, D, Teigner, E, Anthal, E, Yu, E, Vachon-Presseau, E, Saint-Fort, E F, Ferdinand, F, Benbouhoud, F, Pogossova, G, Maultaup, G, Mayrand, G, Duclair, G, Verfaillie, S C J & Presymptomatic Evaluation of Novel or Experimental Treatments for Alzheimer Disease (PREVENT-AD) Research Group 2018, ' Proximity to parental symptom onset and amyloid-β burden in sporadic Alzheimer disease ', JAMA Neurology, vol. 75, no. 5, pp. 608-619 . https://doi.org/10.1001/jamaneurol.2017.5135
Orban, P., C. Madjar, M. Savard, C. Dansereau, A. Tam, S. Das, A. C. Evans, et al. 2015. “Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer’s disease.” Scientific Data 2 (1): 150043. doi:10.1038/sdata.2015.43. http://dx.doi.org/10.1038/sdata.2015.43.